These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17385400)

  • 21. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
    Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
    Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of recombinant erythropoietin in childhood cancer.
    Shankar AG
    Oncologist; 2008 Feb; 13(2):157-66. PubMed ID: 18305061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anemia and lung cancer].
    Bréchot JM; Morère JF
    Rev Pneumol Clin; 2008 Apr; 64(2):81-4. PubMed ID: 18589288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?
    Osterborg A
    Med Oncol; 1998 Aug; 15 Suppl 1():S47-9. PubMed ID: 9785337
    [No Abstract]   [Full Text] [Related]  

  • 26. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
    Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
    Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E
    Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of erythropoietin gene expression and its use in medicine.
    Jelkmann W
    Methods Enzymol; 2007; 435():179-97. PubMed ID: 17998055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anemia in lung cancer patients].
    Méric JB; Morère JF;
    Bull Cancer; 2005 May; 92(5):439-44. PubMed ID: 15932807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes.
    Musto P; Falcone A; Sanpaolo G; Bodenizza C
    Leuk Res; 2006 Apr; 30(4):385-8. PubMed ID: 16219350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K; Braam B; Jie KE; Gaillard CA
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin use in cancer patients: a matter of life and death?
    Steensma DP; Loprinzi CL
    J Clin Oncol; 2005 Sep; 23(25):5865-8. PubMed ID: 16087951
    [No Abstract]   [Full Text] [Related]  

  • 33. Erythropoietin and neuroprotection: a therapeutic perspective.
    Milano M; Collomp R
    J Oncol Pharm Pract; 2005 Dec; 11(4):145-9. PubMed ID: 16595066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current thinking and treatment practices in anaemia--an interactive poll.
    Spivak JL; Cazzola M
    Med Oncol; 2000 Nov; 17 Suppl 1():S32-7. PubMed ID: 11188784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
    Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of erythropoietin and its receptor in neuroblastomas.
    Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
    Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of erythropoietin and other growth factors.
    Indiveri F; Murdaca G
    Rev Clin Exp Hematol; 2002; Suppl 1():7-11. PubMed ID: 12735210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin in clinical practice: current use, effect on survival, and future directions.
    Oster HS; Hoffman M; Prutchi-Sagiv S; Katz O; Neumann D; Mittelman M
    Isr Med Assoc J; 2006 Oct; 8(10):703-6. PubMed ID: 17125118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of serum erythropoietin detection in patients with cancer-related anemia].
    Li LB; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):954-5. PubMed ID: 13129732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anemia in cancer patients before treatment].
    Auclerc G; Meric JB; Pommeyrol A; Rixe O; Khayat D
    Bull Cancer; 2003 Apr; 90 Spec No():S128-32. PubMed ID: 12856424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.